Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New diabetes drug HM15275 enters Mid-Stage trial
Disease control Not yet recruitingThis study tests a new medicine called HM15275 for people with type 2 diabetes. About 180 adults who manage their diabetes with diet and exercise or metformin will receive either the drug or a placebo for 36 weeks. The main goal is to see if the drug improves blood sugar control,…
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Healthy volunteers to test two drug versions in safety study
Knowledge-focused Not yet recruitingThis study compares two similar oral drugs in 60 healthy adults aged 19 to 64. Participants will take a single dose of each drug at different times to measure how the body processes them and to check for side effects. The goal is to gather information, not to treat any disease.
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC